According to Fact.MR’s latest analysis, the South Korea bioactive sphingolipid market is emerging as a high-value, innovation-driven segment within the global specialty lipid industry. The market is estimated to reach USD 0.8 billion in 2026, expanding to USD 1.2 billion by 2036, registering a CAGR of 4.9% over the forecast period.The market is expected to generate approximately...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek